ARCHIVES

Guideline Revisions or Outstanding Investigator Grant Still Controversial

This article is from The Cancer Letter archive.

Vol. 09 No. 47 | December 9, 1983

Download PDF Visit The Full Archive

Related Articles

Clinton Budget For NIH “Disappointing,” AACR executive Director Says

May 7, 1993

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

Rep. Bruce Vento (D-MN) Has Cancer, Will Not Seek Re-Election.

February 4, 2000

As von Eschenbach Prepares For New Assignment, NCI’s 2015 Goal Faces Uncertainty. New Strategic Plan Lists Steps to 2015. “The Vision Is Within Our Grasp,” von Eschenbach Says.

March 10, 2006

IOM Report: Nationwide Crisis Facing Cancer Care

September 13, 2013